This section lists publications by SHORE-C from 2008 to the present. Select a category below or scroll down the page to browse all publications:
To view older publications go to the Publications archive.
LATEST PUBLICATION: Fallowfield L, Langridge C, Jenkins V. Communication skills training for breast cancer teams talking about trials. The Breast. 2013 Dec 14 [Epub ahead of print] http://dx.doi.org/10.1016/j.breast.2013.11.009
von Moos R, Body JJ, Egerdie B, Stopeck A, Brown JE, Damyanov D, Fallowfield LJ, Marx G, Cleeland CS, Patrick DL, Palazzo FG, Qian Y, Braun A, Chung K. Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid Support Care Cancer 21(12):3497-507, 2013. doi: 10.1007/s00520-013-1932-2
Pivot X, Gligorov J, Müller V, Barrett-Lee P, Verma S, Knoop A, Curigliano G, Semiglazov V, López-Vivanco G, Jenkins V, Scotto N, Osborne S, Fallowfield LJ for the PrefHer Study Group Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study. The Lancet Oncology 14(10): 962-70, 2013 doi:10.1016/S1470-2045(13)70383-8
Migliore M, Lees B, Treasure T, Fallowfield LJ Randomized controlled trial of pulmonary metastasectomy in colorectal cancer: PulMiCC International is open in Italy. Oncologist (18)5: 637, 2013 doi:10.1634/theoncologist.2012-0476
Harder H, Ballinger R, Langridge C, Ring A, Fallowfield LJ Adjuvant chemotherapy in elderly women with breast cancer: patients' perspectives on information giving and decision making, Psycho-Oncology (22)12: 2729-2735, 2013, doi:10.1002/pon.3338
Jenkins V*, Catt S, Banerjee S, Gourley C, Montes A, Solis-Trapala I, Monson K and Fallowfield LJ Patients’ and oncologists’ views on the treatment and care of advanced ovarian cancer in the UK: results from the ADVOCATE study, British Journal of Cancer 108(11): 2264-71, 2013 doi:10.1038/bjc.2013.223
Lin NU, et al., International guidelines for management of metastatic breast cancer (MBC) from the European
School of Oncology (ESO)eMBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancerThe Breast 22(3): 203-10, 2013, http://dx.doi.org/10.1016/j.breast.2013.03.006
Jenkins V, Farewell V, Farewell D, Darmanin J, Wagstaff J, Langridge C, Fallowfield LJ. Drivers and barriers to patient participation in RCTs. British Journal of Cancer 108, 1402-1407, 2013, doi:10.1038/bjc.2013.113
Jenkins V, Farewell D, Farewell V, Batt L, Wagstaff J, Langridge C, Fallowfield LJ Teams Talking Trials: Results of an RCT to improve the communication of cancer teams about treatment trials. Contemporary Clinical Trials 35(1): 43-51, 2013 doi:10.1016/j.cct.2013.02.003
Ring A, Harder H, Langridge C, Ballinger RS, Fallowfield LJ Adjuvant chemotherapy in elderly women with breast cancer (AChEW): an observational study identifying MDT perceptions and barriers to decision making. Annals of Oncology 24(5): 1211-9, 2013. doi:10.1093/annonc/mds642
Fallowfield LJ, Francis A, Catt S, Mackenzie M, Jenkins V. Time for a low-risk DCIS trial: harnessing public and patient involvement, Lancet Oncology 13(12): 3055-64, 2012. doi:10.1016/S1470-2045(12)70503-X
Simcock R, Fallowfield LJ, Monson K, Solis-Topala I, Parlour L, Langridge C, Jenkins V, on behalf of the ARIX Steering Committee. ARIX: A randomised trial of acupuncture v oral care sessions in patients with chronic xerostomia following treatment of head and neck cancer, Annals of Oncology 24(3): 776-783, 2012. doi: 10.1093/annonc/mds515
Harder H, Parlour L, Jenkins V Randomised controlled trials of yoga interventions for women with breast cancer: a systematic literature review. Supportive Care In Cancer 20(12): 3055-64 2012. doi:10.1007/s00520-012-1611-8
Fallowfield LJ, von Moos R, Costa L, Stopeck A, Clemons M, Clarke N, Braun A, Chung K. Weighing Bone-targeted Treatment Options for Patients with Solid Tumours and Skeletal Complications from Metastatic Disease. European Oncology & Haematology, 2012;8(3):148–55.
Catt S, Chalmers A, Critchley G, Fallowfield LJ. Supportive follow-up in patients treated with radical intent for high-grade glioma. CNS Oncology, September 2012, Vol. 1, No. 1, Pages 39-48.
Cleeland CS, Body JJ, Stopek A, von Moos R, Fallowfiled LJ et. al. Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of Denosumab and Zoledronic Acid. 2012, 119(4):832-838 doi:10.1002/cncr.27789
Martin M, Bell R, Bourgeois H et al. Bone-related complications and quality of life in advanced breast cancer: results from a randomised phase III trial of Denosumab versus Zoledronic Acid. Clin Cancer Res, 2012 Sep 1;18(17):4841-4849. Epub 2012 Aug 14. doi:10.1158/1078-0432.CCR-11-3310
Gentry-Maharaj A, Sharma A, Burnell M, Ryan A, Amso NN, Seif MW, Turner G, Brunell C, Fletcher G, Rangar R, Fallowfield LJ, Campbell S, Jacobs I, Menon U. Acceptance of transvaginal sonography by postmenopausal women participating in the United Kingdom Collaborative Trial of Ovarian Cancer Screening. Ultrasound Obstetrics and Gynecology 2012, 41(1):73-79. doi:10.1002/uog.12262.
Vadhan-Raj S, von Moos R, Fallowfield LJ, Patrick DL, Goldwasser F, Cleeland CS, Henry DH, Novello S, Hungria V, Qian Y, Feng A, Yeh H, Chung K. Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid. Annals of Oncology 2012, 23(12): 3045-51, doi:10.1093/annonc/mds175
Fallowfield LJ, Solis-Trapala I, Jenkins V Evaluation of an educational program to improve communication with patients about early-phase trial participation. The Oncologist, 2012;17:377-383. doi:10.1634/theoncologist.2011-0271 (see also accompanying editorial: Flamm, et al. Communicating About Phase I Trials: Objective Disclosures Are Only A First Step, The Oncologist 2012; 17:466-468)
Cardoso F, et al., 1st International consensus guidelines for advanced breast cancer (ABC 1), The Breast (2012) 21(3):242-252, doi:10.1016/j.breast.2012.03.003
Fallowfield LJ, Kilburn LS, Langridge C, Snowdon CF, Bliss JM, Coombes RC on behalf of the IES Trial Steering Committee Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation. British Journal of Cancer (2012), 1-6. doi:10.1038/bjc.2012.43
Ford E, Catt S, Chalmers A, Fallowfield LJ. Systematic review of supportive care needs in patients with primary malignant brain tumours. Neuro-Oncology Advance Access published February 3, 2012. doi:10.1093/neuonc/nor229
Matza LS, Fallowfield LJ, Chung K, Currie BM, Van Brunt K, Patrick DL. Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases. Support Care Cancer, 12 December 2011. doi:10.1007/s00520-011-1356-9
Talk summary by Fallowfield LJ. Talking to patients about clinical trial entry from Phase I to Phase III. Le Journal du Cancer de L'Institut Jules Bordet, No 20, 2011, p.18.
Cardoso F, Fallowfield LJF, Costa A, Castiglione M, Senkus E, on behalf of the ESMO Guidelines Working Group. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 22 (Supplement 6): vi25-v130, 2011. doi:10.1093/annonc/mdr372
Letter to the British Medical Journal, "What should women do in the meantime?", Fallowfield LJF. BMJ 2011;343:d7544.
Monson K, Parlour L, Simcock R, Fallowfield LJ, Jenkins V. Group recruitment sessions enhance patient understanding in a small multi-centre phase III clinical trial. Contemp Clin Trials (2012) 33(2);286-290 doi:10.1016/j.cct.2011.11.003
R Leonard, R Ballinger, D Cameron, P Ellis, L Fallowfield, M Gosney, L Johnson, L S Kilburn, A Makris, J Mansi, M Reed, A Ring, A Robinson, P Simmonds, G Thomasand J M Bliss. Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase? British Journal of Cancer (2011) 105, 1260-1266. doi:10.1038/bjc.2011.377
Fallowfield LJ, Fleissig, A. The value of progression-free survival to patients with advanced-stage cancer. Nat. Rev. Clin. Oncol. 9,41-47 (2012); published online 18 Ocotber 2011. doi:10.1038/nrclinpnc.2011.156
Jenkins V, Harder H, Babar M, Merry S, Newbury S, Kissin M, Zammit C. A pilot study to examine the experiences and attitudes of women with breast cancer towards one versus two-step axillary surgery. The Breast, February 2012, 21 (1)72-76 doi:10.1016/j.breast.2011.08.125
Jenkins V, Trapala SI, Parlour L, Langridge CI, Fallowfield LJ. The views of patients and the general public about expensive anti-cancer drugs in the NHS: a questionnaire-based study. Journal of the Royal Society of Medicine, Short Reports (2011) doi:10.1258/shorts.2011.011050
Ring A, Reed M, Leonard R, Kunkler I, Muss H, Wildiers H, Fallowfield L, Jones A and Coleman R. The treatment of early breast cancer in women over the age of 70. British Journal of Cancer (2011) 105, 189-193
Scott S, Jones D, Ballinger R, Bendelow G, Fulford B. The slide to pragmatism: A values-based understanding of 'dangerous' personality disorders. Health Sociology Review, (2011) 20(2): 157-171
Treasure T, Fallowfield LJ, Lees B, Farewell V. Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial. Thorax 1 Feb 2012 67: 185-187 doi:10.1136/thoraxjnl-2011-200015
Ballinger R, Ford E, Pennery E, Jenkins V, Ring A, Fallowfield LJ. Specialist breast care and research nurses' attitudes to adjuvant chemotherapy in older women with breast cancer. European Journal of Oncology Nursing. February 2012;16(1):78-86. E-Published 7th May 2011 ahead of print. doi:10.1016/j.ejon.2011.03.011
Fallowfield LJ, Solis-Trapala I, Jones A, Barrett J, Langridge C, Jenkins V. Discussing expensive anti-cancer drugs. British Journal of Healthcare Management 17(5): 206 - 212 (May 2011)
Ford E, Jenkins V, Fallowfield L, Stuart N, Farewell D, Farewell V. Clinicians' attitudes towards clinical trials of cancer therapy. British Journal of Cancer, (12 April 2011) doi:10.1038/bjc.2011.119
Catt S, Langridge C, Fallowfield L, Talbot DC, Jenkins V. Reasons given by patients for participating, or not, in Phase 1 cancer trials, Eur J Cancer (2011), doi:10.1016/j.ejca.2011.02.020
Burnell M, Gentry- Maharaj A, Ryan A, Apostolidou S, Habib M, Kalsi J, Skates S, Parmar M, Seif MW, Amso NN, Godfrey K, Oram D, Herod J, Williamson K, Jenkins H, Mould T, Woolas R, Murdoch J, Dobbs S, Leeson S, Cruickshank D, Campbell S, Fallowfield L, Jacobs I, Menon U Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials Trials 2011, 12:61 doi:10.1186/1745-6215-12-61
Jacobs I, Gentry- Maharaj A, Burnell M, Manchanda R, Singh N, Sharma A, Ryan A, Seif MW, Amso NN, Turner G, Brunell C, Fletcher G, Rangar R, Ford K, Godfrey K, Lopes A, Oram D, Herod J, Williamson K, Scott I, Jenkins H, Mould T, Woolas R, Murdoch J, Dobbs S, Leeson S, Cuickshank D, Skates SJ, Fallowfield L, Parmar M, Campbell S, Menon U. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort Lancet Oncology 2011;12:38-48. doi:10.1016/S1470-2045(10)70268-0
Catt S, Anderson J, Chalmers A, Fallowfield LJ A UK-wide survey of follow-up practices for patients with high-grade glioma treated with radical intent. Journal of Evaluation in Clinical Pratice 2011 Feb;17(1):1-6. doi: 10.1111/j.1365-2753.2009.01292.x.
Dixon J, Renshaw L, Langridge C, Young O, McHugh M, Williams L, Murray J, Macaskill J, McCaig F, Dixon O, Fallowfield LJ. Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability. Breast Cancer Research and Treatment, 125(3):741-749 Feb 2011. doi:10.1007/s10549-010-1091-9
Jenkins V, Solis-Trapala I, Langridge C, Catt S, Talbot DC, Fallowfield LJ What oncologists believe they said and what patients believe they heard: an analysis of Phase 1 Trial discussions. JCO January 1, 2011 vol. 29 no. 1 61-68 doi:10.1200/JCO.2010.30.0814
Treasure T, Fiorentino F, Hunt I, Fallowfield LJ, Utley M Current concepts: pulmonary metastasectomy for colorectal cancer. The European Journal of Oncological Medicine, Vol II, Issue II June 2010, June 2010.
Jenkins V, Farewell D, Batt L, Maughan T, Branston L, Langridge C, Parlour L, Farewell V, Fallowfield LJ The attitudes of 1066 patients with cancer towards participation in randomised clinical trials. British Journal of Cancer (2010) 103, 1801-1807, doi:10.1038/sj.bjc.6606004
Mayer M, Hunis A, Oratz R, Glennon C, Spicer P, Caplan E, Fallowfield LJ Living with metastatic breast cancer: a global patient survey. Commun Oncol 2010;7:406–412.
Fallowfield LJ, Fleissig A, Barrett J, Menon U, Jacobs I, Kilkerr J and Farewell V. Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21,715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening. British Journal of Cancer 103, 454-461, doi:10.1038/sj.bjc.6605809
Treasure T, Fallowfield LJ, Lees B. Pulmonary Metastasectomy on Colorectal Cancer: The PulMiCC Trial. Journal of Thoracic Oncology, 2010:5, S203-S206. doi:10.1097/JTO.0b013e3181dca239
Fallowfield LJ, Stebbing J, Braybrooke, J, Langridge C, Jenkins V The preferences and experiences of different bisphosphonate treatments in women with breast cancer. Psycho-Oncology (2010). doi:10.1002/pon.1781
Smith AB, Fallowfield LJ, Stark DP, Velikova G, Jenkins V A Rasch and confirmatory factor analysis of the General Health Questionnaire (GHQ)-12. Health and Quality of Life Outcomes 2010,8:45, doi:10.1186/1477-7525-8-45
Jenkins V, Anderson, J, Fallowfield LJ Communication and informed consent in phase 1 trials: a review of the literature from January 2005 to July 2009. Supportive Care In Cancer Volume 18, Number 9, 1115-1121 doi:10.1007/s00520-010-0836-7
Stifel F, Barth J, Bensing J, Fallowfield LJ, Jost L, Razavi D, Kiss A for the participants Communication skills training in oncology: a position paper based on a consensus meeting among European experts in 2009. Annals of Oncology, doi:10.1093/annonc/mdp564
Fallowfield LJ The challenge of interacting with patients in oncology. European Journal of Cancer, Volume 45, Supplement 1, Joint ECCO 15 - 34th ESMO Multidisciplinary Congress Education Book, September 2009, pp.445-446. doi:10.1016/S0959-8049(09)70083-8
Fallowfield LJ. The clinical importance of patient adherence to therapy. Advances in Breast Care, June 2009, Vol. 6.2, 9-11.
Jenkins V, Low R, Mitra S. Hearing sensitivity in women following chemotherapy treatment for breast cancer: results from a pilot study, The Breast (2009), doi: 10.1016/j.breast.2009.07.004
Fatima Cardoso, Philippe L. Bedard, Eric P. Winer, Olivia Pagani, Elzbieta Senkus-Konefka, Lesley J. Fallowfield, Stella Kyriakides, Alberto Costa, Tanja Cufer, Kathy S. Albain, and on behalf of the ESO-MBC Task Force International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy. Journal of the National Cancer Institute Advance Access published on August 5, 2009. doi:10.1093/jnci/djp235
Simcock R, Fallowfield LJF, Jenkins V Group acupuncture to relieve radiation induced xerostomia: a feasibility study. Acupuncture Medicine 2009;Ser. 27(3), 109-13.
Fallowfield LJF What is quality of life? May 2009.
Fallowfield LJF, Jenkins V Quality of life issues during adjuvant endocrine therapy. Cancer Treatment and Research 2009; 151 353-65. doi:10.1007/978-0-387-75115-3_22
Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, Lewis S, Davies S, Philpott S, Lopes A Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 2009; 10: 327-40. doi: 10.1016/S1470-2045(09)70026-9.
Ballinger RS, Fallowfield LJ Quality of life and patient-reported outcomes in the older breast cancer patient. Clinical Oncology (2009) 21: 140-155. doi:10.1016/j.clon.2008.11.003
Treasure T, Fallowfield LJ, Farewell V, Ferry D, Lees B, Leonard P, Macbeth F, Utley M (for the Pulmonay Metastasectomy in Colorectal Cancer (PulMiCC) trial development group). Pulmonary metastasectomy in colorectal cancer: Time for a trial. European Journal of Surgical Oncology (2009), doi: 10.1016/j.ejso.2008.12.005
Fallowfield LJ, George D Section introduction: Introduction to the sessions on 'Debate: Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors'. Breast Cancer Research 2008, 10(Suppl 4):S6. doi: 10.1186/bcr2166
Fallowfield LJ Short communication: Psychosocial aspects of risk appraisal Breast Cancer Research 2008, 10(Suppl 4):S14. doi:10.1186/bcr2174
Cuzick J, Sestak I, Cella D, Fallowfield LJ, on behalf od the ATAC Triallists' Group Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial. Early online publication doi:10.1016/S1470-2045(08)70259-6
Ballinger R, Fortes Mayer K, Lawrence G, Fallowfield LJ Patients' decision-making in a UK specialist centre with high mastectomy rates. The Breast (2008). doi:10.1016/j.breast.2008.08.001
Jenkins V, Amroisine L, Atkins L, Cuzick J, Howell A, Fallowfield LJ Effects of Anastrozole on cognitive performance in postmeopausal women: a randomised, double-blind chemoprevention trial (IBIS II). Lancet Oncology 2008, 9: 953-961. doi: 10.1016/S1470-2045(08)70207-9.
Catt A, Chalmers A, Fallowfield LJ Psychosocial and supportive-care needs in high-grade glioma. Lancet Oncology 2008; 9:884-91. doi:10.1016/S1470-2045(08)70230-4
Smith AB, Rush R, Fallowfield LJ, Velikova G, Sharpe M Rasch fit statistics and sample size considerations for polytomous data. BMC Medical Research Methodology 2008, 8:33. doi:10.1186/1471-2288-8-33
Fallowfield LJ Treatment decision-making in breast cancer: the patient-doctor relationship. Breast Cancer Res Treat, published online 11 June 2008. doi:10.1007/s10549-008-0077-3
Lansdown M, Martin L, Fallowfield LJ Patient-physician interactions during early breast cancer treatment: results from an international online survey. Current Medical Research and Opinions, Vol.24, No.7, 2008. doi:10.1185/03007990802135042
Fallowfield LJ The importance of communication in treating women with breast cancer. Oncology, Vol. 22, No.6, May 2008.
Fallowfield LJ, Jenkins V, Coleman R Which bisphosphonates do oncologists prescribe for women with metastatic breast cancer and why? Results of a UK survey. The Breast (2008), doi:10.1016/j.breast.2008.02.009
Fallowfield LJ There's many a slip twixt cup and lip: adherence issues in cancer therapy. Nature Clinical Practice Oncology, published online 15 January 2008, doi: 10.1038/ncponc1043
Fallowfield LJ, Jenkins V Psychosocial issues in breast cancer in Dixon MJ (ed.) Companion to Specialist Practice volume in Breast Surgery Fourth Edition Elseview, chapter 16, 245-257.
Fallowfield LJ. The clinical importance of patient adherence to therapy. Section Three, chapter 7; pp. 44-47, Current Innovations in the Treatment and Prevention of Breast Cancer, The Jephcott Symposium and Lecture Series.
Fallowfield LJ, Jenkins V Psychosocial issues in breast cancer in Dixon MJ (ed.) Companion to Specialist Practice volume in Breast Surgery Fourth Edition Elseview, chapter 16, 245-257.
Fallowfield LJ, Jenkins V Current Concepts of Communication Skills Training in Oncology. In Stiefel F (Ed) Communication in Cancer Care. Springer-Verlag Berlin Heidelberg 2006: 105-112
Fallowfield LJ, Jenkins V Psychosocial Issues in Breast Cancer. In Dixon JM, Breast Surgery: A Comparison to Specialist Surgical Practice. 3rd Edition Elsevier Saunders 2006: 235-249
Fallowfield LJ Psychosocial Aspects. In Baum M, Henderson C (Eds) Classic Papers in Breast Disease. ISIS Medical Media Ltd 2004: 372-380
Fallowfield LJ Communication with the patient and family in palliative medicine. In Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press 2003: 100-107
Fallowfield LJ, Jenkins V Communication. In Souhami RL, Tannock I, Hohenberger P, Horiot J-C. (Eds) Oxford Textbook of Oncology (2nd edition). Oxford: Oxford University Press 2001: 1049-1059
Roter D, Fallowfield LJ Principles of training medical staff in psychosocial and communication skills. In Holland JC. (Ed) Psycho-Oncology. New York, Oxford: Oxford University Press 1998: 1074-1082
Fallowfield LJ Psychological aspects of surgical management. In Taylor I, Cooke TG, Guillou PJ. (Eds) Essential General Surgical Oncology. London: Churchill Livingston 1996: 421-429
Fallowfield LJ Psychological implications of tamoxifen treatment in women at high risk to breast cancer. In Maltoni C, Soffritti M, Davies W. (Eds) Proceedings of 'The Scientific Basis of Cancer Chemoprevention'. Berlin: Elselvier Science 1996
Fallowfield LJ Breast Cancer. In Baum A, McManus C, Newman S, Wienman J, West R. (Eds) Cambridge Handbook of Psychology, Health and Medicine. Cambridge: Cambridge University Press 1997: 385-390^ Top